Yeast protein expression service

Common causes of batch fluctuations in yeast expression include differences in clone stability, inconsistent induction conditions, variations in cell density and dissolved oxygen, as well as changes in culture media and operational details across batches. We usually improve batch consistency by screening and fixing high-yield, stable clones, and standardizing induction parameters including duration, temperature, inducer concentration and culture cycle. For projects requiring long-term supply, we also recommend adopting a single batch of seed bank system to reduce fluctuations.

This phenomenon usually indicates insufficient secretion efficiency, which may result from poor matching of signal peptides, protein retention caused by excessive folding stress, or saturation of the secretory pathway. We will first evaluate whether the target protein is more suitable for intracellular expression. Meanwhile, secretion levels can be improved by replacing signal peptides, adjusting construct boundaries or optimizing culture and induction intensity. If necessary, the route of intracellular expression followed by lysis and purification can be adopted to increase overall yield and controllability.

Although secretory expression can reduce hybrid proteins introduced by cell lysis, some yeast hosts still secrete a certain amount of background proteins, leading to more impurity bands during purification. We usually strengthen the washing intensity of affinity purification and optimize salt concentration and pH conditions to cut down non-specific binding. If customers have higher purity requirements, additional polishing steps such as ion exchange or gel filtration can be performed after affinity purification to obtain purer and more homogeneous target proteins.

The yeast system has certain potential for expressing partial membrane proteins or hydrophobic proteins, yet the overall difficulty remains relatively high. In particular, multi-transmembrane proteins often require more sophisticated expression and purification conditions. We generally recommend conducting small-scale feasibility tests first, and improving success rates through construct design including truncation, fusion tags and altered expression formats. If high-quality membrane proteins are required for structural research, insect or mammalian expression systems are usually more advantageous.